U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
6951169511Stem Cell Recruitment in Osteoporosis TherapyCompletedNo Results AvailableLow Bone DensityDrug: Teriparatide|Drug: Alendronate|Dietary Supplement: calcium and vitamin Dhttps://ClinicalTrials.gov/show/NCT01656629
6951269512Hydroxycobalamin and Rural Emergency Medical Services Cyanide Exposure Patients: A Cost AnalysisNot yet recruitingNo Results AvailableCyanide PoisoningDrug: Cyanide antidote administrationhttps://ClinicalTrials.gov/show/NCT01656616
6951369513Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated TransplantationRecruitingNo Results AvailableInfusion ReactionsBiological: unlicensed CBUhttps://ClinicalTrials.gov/show/NCT01656603
6951469514High Protein and Exercise Therapy Plus Nocturnal Enteral Feeding in Juvenile-onset Pompe DiseaseWithdrawnNo Results AvailableGlycogen Storage Disease Type IIOther: High Protein and Exercise Therapy along-with Nocturnal Enteral Feedinghttps://ClinicalTrials.gov/show/NCT01656590
6951569515Pexacerfont for Stress-induced Food CravingRecruitingNo Results AvailableDaily Oral Pexacerfont for 28 Days (300 mg/Day Loading Dose for 7 Days, Followed|PlaceboDrug: Pexacerfonthttps://ClinicalTrials.gov/show/NCT01656577
6951669516Clinical Outcomes in Persons With HIV Acquired Early in LifeRecruitingNo Results AvailableHIV|Childhood|Natural History|Cardiac|ARThttps://ClinicalTrials.gov/show/NCT01656564
6951769517MILES-4: Study Comparing Gemcitabine and Pemetrexed, With or Without Cisplatin, in Patients With Nonsquamous Lung CancerRecruitingNo Results AvailableNon-small Cell Lung Cancer Metastatic|Non-small Cell Lung Cancer Stage IIIBDrug: Gemcitabine|Drug: Pemetrexed|Drug: Cisplatinhttps://ClinicalTrials.gov/show/NCT01656551
6951869518A Study of Reolysin For Patients With Advanced/Metastatic Breast CancerRecruitingNo Results AvailableMetastatic Breast CancerDrug: Paclitaxel|Drug: Reolysinhttps://ClinicalTrials.gov/show/NCT01656538
6951969519A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease PatientsCompletedNo Results AvailableAlzheimer's DiseaseDrug: Gantenerumab|Drug: Gantenerumab|Drug: Gantenerumab|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01656525
6952069520Zometa Study in Pediatric Acute Lymphoblastic LeukemiaSuspendedNo Results AvailableOsteoporosisDrug: zolendronic acid|Drug: calcium & vitamin Dhttps://ClinicalTrials.gov/show/NCT01656512
6952169521Effect of AXOS on the Colon Metabolism in Healthy VolunteersCompletedNo Results AvailableGut HealthDietary Supplement: Arabinoxylanoligosaccharides|Dietary Supplement: Maltodextrinehttps://ClinicalTrials.gov/show/NCT01656499
6952269522Stereotactic Radiation to Decrease Pancreatic SecretionsCompletedHas ResultsPancreatic FistulaeRadiation: Stereotactic Radiationhttps://ClinicalTrials.gov/show/NCT01656486
6952369523Evaluating the Effectiveness of Motivational Interviewing and a Dialectical Therapy Skills- Based Intervention for YouthCompletedNo Results AvailableConcurrent DisordersOther: MI and DBT|Other: MI and DBThttps://ClinicalTrials.gov/show/NCT01656473
6952469524Stereotactic Body Radiation for Consolidation After Standard Chemoradiation for Stage 3 Lung CancerActive, not recruitingHas ResultsLung CancerRadiation: Stereotactic radiation Arm 1|Radiation: Stereotactic radiation Arm 2|Radiation: Stereotactic radiation Arm 3|Radiation: Stereotactic radiation Arm 4https://ClinicalTrials.gov/show/NCT01656460
6952569525Scleroderma Registry & Repository at the Hospital for Special SurgeryRecruitingNo Results AvailableSclerodermahttps://ClinicalTrials.gov/show/NCT01656447
6952669526Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448)TerminatedHas ResultsContraceptionDrug: NOMAC-E2|Drug: NETA-EE|Other: Placebo|Drug: ethinylestradiol (EE)|Drug: ferrous fumaratehttps://ClinicalTrials.gov/show/NCT01656434
6952769527Assessment of Risk in Chronic Airways Disease EvaluationActive, not recruitingNo Results AvailableChronic Obstructive Pulmonary Disease (COPD)https://ClinicalTrials.gov/show/NCT01656421
6952869528A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8150 (MK-8150-002)CompletedNo Results AvailableHypertension|Isolated Systolic HypertensionDrug: MK-8150|Drug: Placebo for MK-8150https://ClinicalTrials.gov/show/NCT01656408
6952969529A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012)TerminatedNo Results AvailableAsthmaDrug: MK-1029 10 mg|Drug: MK-1029 30 mg|Drug: MK-1029 150 mg|Drug: Montelukast 10 mg|Drug: Placebo|Drug: MK-1029 1 mg or 3 mg|Drug: Montelukast 10 mg + MK-1029https://ClinicalTrials.gov/show/NCT01656395
6953069530Safety, Efficacy, and Pharmacokinetics of Amphotericin B Lipid ComplexCompletedNo Results AvailableInvasive CryptococcosisDrug: ABLChttps://ClinicalTrials.gov/show/NCT01656382
6953169531Comparative Study Between Delorme Operation With or Without Postanal Repair in Treatment of Complete Rectal ProlapseCompletedNo Results AvailableRectal ProlapseProcedure: Group I: delorme operation only.|Procedure: delorme operation with post anal repairhttps://ClinicalTrials.gov/show/NCT01656369
6953269532Phase I Safety and Immunogenicity of Live Attenuated Influenza H5 Candidate Vaccine Strain A/17/Turkey/Turkey/05/133 (H5N2) in Healthy Thai VolunteersCompletedNo Results AvailablePreventive Avian FluBiological: Avian Flu Vaccine|Biological: Placebohttps://ClinicalTrials.gov/show/NCT01656356
6953369533Belatacept and Risk of Post-transplant Lymphoproliferative Disorder in US Renal Transplant RecipientsActive, not recruitingNo Results AvailableKidney Transplantation|Transplantation, KidneyDrug: Calcineurin inhibitors (CNI)|Drug: Belatacepthttps://ClinicalTrials.gov/show/NCT01656343
6953469534A Study to Assess the Effects of 2 Different Prothrombin Complex Concentrates on the Pharmacodynamics of Rivaroxaban in Healthy Adult VolunteersCompletedNo Results AvailableHealthyDrug: Rivaroxaban 20 mg twice daily|Drug: Rivaroxaban 20 mg once daily|Drug: Profilnine SD|Drug: Beriplex P/N|Other: Salinehttps://ClinicalTrials.gov/show/NCT01656330
6953569535Rehabilitation of Patients After Subarachnoid HemorrhageActive, not recruitingNo Results AvailableSAHOther: Early multidisciplinary rehabilitationhttps://ClinicalTrials.gov/show/NCT01656317
6953669536Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone TherapyCompletedHas ResultsAdenocarcinoma of the Prostate|Recurrent Prostate Cancer|Stage I Prostate Cancer|Stage IIA Prostate Cancer|Stage IIB Prostate Cancer|Stage III Prostate CancerBiological: bevacizumab|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01656304
6953769537An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid ArthritisRecruitingNo Results AvailableArthritis|Arthritis, Rheumatoid|Joint Diseases|Musculoskeletal Diseases|Rheumatic Diseases|Connective Tissue Diseases|Autoimmune DiseasesProcedure: Magnetic resonance imaging (MRI)|Other: Conventional biochemical and clinical examinationshttps://ClinicalTrials.gov/show/NCT01656278
6953869538Study of ARQ 197 in Hepatocellular Carcinoma (HCC)CompletedNo Results AvailableAdvanced Hepatocellular CarcinomaDrug: ARQ 197https://ClinicalTrials.gov/show/NCT01656265
6953969539Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete RemissionRecruitingNo Results AvailableAcute Myeloid LeukemiaDrug: Phase I- Cytarabine & Eltrombopag|Drug: Phase II- Sequence A|Drug: Phase II- Sequence Bhttps://ClinicalTrials.gov/show/NCT01656252
6954069540Dose Range Finding Study of Fedovapagon in Men With NocturiaCompletedNo Results AvailableNocturiaDrug: fedovapagon 1 mg|Drug: fedovapagon 2 mg|Drug: fedovapagon 4 mg|Drug: Placebo ( sugar pill)https://ClinicalTrials.gov/show/NCT01656239

* Görseller ve İçerik tekif hakkına sahip olabilir